AcelRx Pharmaceuticals
ACRX
$0.76
Share price
3.95%
Change (1 day)
-68.03%
Change (1 year)
Categories
Earnings for AcelRx Pharmaceuticals (ACRX)
Earnings in 2023 (TTM): -$13.27 M
According to AcelRx Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$13.27 M. In 2022 the company made an earning of $47.76 M an increase over its 2021 earnings that were of -$35.1 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for AcelRx Pharmaceuticals from 2010 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$13.27 M | -127.76% |
| 2022 | $47.76 M | -236.11% |
| 2021 | -$35.1 M | -13.08% |
| 2020 | -$40.38 M | -24.16% |
| 2019 | -$53.24 M | 12.92% |
| 2018 | -$47.15 M | -9.7% |
| 2017 | -$52.21 M | 20.88% |
| 2016 | -$43.2 M | 82.71% |
| 2015 | -$23.64 M | -29.12% |
| 2014 | -$33.36 M | 42.38% |
| 2013 | -$23.43 M | -24.63% |
| 2012 | -$31.08 M | 60.61% |
| 2011 | -$19.36 M | 70.22% |
| 2010 | -$11.37 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Recro Pharma
REPH | $3.76 M | -128.38% | 🇺🇸 USA |
 Cara Therapeutics
CARA | -$0.13 B | 806.31% | 🇺🇸 USA |